PharmaCI - The Competitive Intelligence Solution

Original Airing Date:
Wednesday, May 25, 2005

The need for timely well-informed, strategic business decisions in the life-sciences industry has never been greater. Pharmaceutical and biotechnology companies are under constant stress to bring drugs to market quicker, maximize the return on each new drug, comply with stringent government regulations, understand the impact of patent expiration on drug portfolios, and respond to competition from other pharmaceuticals and generic drugs.

Verity and Raritan Technologies have jointly developed PharmaCI, a competitive intelligence solution that addresses the specific needs of pharmaceutical and biotechnology companies. PharmaCI allows companies to collect, organize and analyze information from internal and external sources so they can support strategic decisions with the most up-to-date market and competitive intelligence.

PharmaCI provides your organization with the information you need to:

Maintain a competitive edge globally.
Evaluate companies that are appropriate partners, or merger and acquisition candidates.
Monitor the competition and their current research or products in therapeutic areas.
Continue, pursue, or terminate projects (compounds/molecules/devices).
Identify trends and new opportunities such as different or novel ("off-label") uses for existing products.
Research recalls and adverse effects to determine the impact on existing products.
Stay in touch with industry events and local opinion.

Join Maya Natarajan, PhD (Verity Life Sciences Vertical Solutions Manager), Barry Freindlich (CEO, Raritan Technologies), and Ted Sullivan, PhD (CTO, Raritan Technologies) as they detail key strategies of using Verity products to allow you to make timely well-informed, strategic business decisions.

The Q&A Document from the webinar is also available.